Literature DB >> 24092437

Syngeneic murine metastasis models: B16 melanoma.

Raffaella Giavazzi1, Alessandra Decio.   

Abstract

The murine B16 melanoma is one of the most used tumor models, its application having been used to determine the mechanisms associated with the metastatic process and the development of anticancer therapies. The B16 melanoma was originally established by Fidler and collaborators as a tumor line metastasizing to the lung. Since that time a variety of cell lines have been derived, in vitro or in vivo, having different metastatic behaviors.The methods used to obtain artificial metastases to the lung through the intravenous injection of B16 melanoma cells and spontaneous metastasis formation following cancer cell growth in the footpad are described in this chapter.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24092437     DOI: 10.1007/978-1-4614-8244-4_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  A modeling platform for the lymphatic system.

Authors:  Javier Ruiz-Ramírez; Arturas Ziemys; Prashant Dogra; Mauro Ferrari
Journal:  J Theor Biol       Date:  2020-02-28       Impact factor: 2.691

2.  LINCRNA00273 promotes cancer metastasis and its G-Quadruplex promoter can serve as a novel target to inhibit cancer invasiveness.

Authors:  Samarjit Jana; Jagannath Jana; Kartick Patra; Soma Mondal; Jyotsna Bhat; Arnab Sarkar; Pallabi Sengupta; Anindya Biswas; Meghomukta Mukherjee; Satya Prakash Tripathi; Rahul Gangwal; Joyita Hazra; Abhay T Sangamwar; Gopeswar Mukherjee; Shamee Bhattacharjee; Deba Prasad Mandal; Subhrangsu Chatterjee
Journal:  Oncotarget       Date:  2017-11-17

3.  Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.

Authors:  Marine Potez; Verdiana Trappetti; Audrey Bouchet; Cristian Fernandez-Palomo; Esra Güç; Witold W Kilarski; Ruslan Hlushchuk; Jean Laissue; Valentin Djonov
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

4.  Citrus unshiu peel suppress the metastatic potential of murine melanoma B16F10 cells in vitro and in vivo.

Authors:  Eun Ok Choi; Hyesook Lee; Hyun HwangBo; Da Hye Kwon; Min Yeong Kim; Seon Yeong Ji; Su Hyun Hong; Gi-Young Kim; Cheol Park; Hye-Jin Hwang; Sung-Kwon Moon; Seok-Joong Yun; Wun-Jae Kim; Yung Hyun Choi
Journal:  Phytother Res       Date:  2019-09-04       Impact factor: 5.878

Review 5.  Detecting Tumor Metastases: The Road to Therapy Starts Here.

Authors:  M E Menezes; S K Das; I Minn; L Emdad; X-Y Wang; D Sarkar; M G Pomper; P B Fisher
Journal:  Adv Cancer Res       Date:  2016-08-17       Impact factor: 6.242

6.  Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.

Authors:  Stephen L Shiao; Kathleen M Kershaw; Jose J Limon; Sungyong You; Junhee Yoon; Emily Y Ko; Jlenia Guarnerio; Alka A Potdar; Dermot P B McGovern; Shikha Bose; Tahir B Dar; Paul Noe; Jung Lee; Yuzu Kubota; Viviana I Maymi; Madison J Davis; Regina M Henson; Rachel Y Choi; Wensha Yang; Jie Tang; Matthew Gargus; Alexander D Prince; Zachary S Zumsteg; David M Underhill
Journal:  Cancer Cell       Date:  2021-07-29       Impact factor: 38.585

7.  Modulation of therapy-induced senescence by reactive lipid aldehydes.

Authors:  A C Flor; A P Doshi; S J Kron
Journal:  Cell Death Discov       Date:  2016-07-04

8.  ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells.

Authors:  Fei Chang; Yunpeng Zhang; Jun Mi; Qian Zhou; Fuxiang Bai; Xin Xu; David E Fisher; Qinfeng Sun; Xunwei Wu
Journal:  Cancer Sci       Date:  2018-09-23       Impact factor: 6.716

9.  Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor Models.

Authors:  Ludmila A Alekseeva; Aleksandra V Sen'kova; Marina A Zenkova; Nadezhda L Mironova
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-08       Impact factor: 8.886

10.  Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.

Authors:  Vanessa S Fear; Catherine A Forbes; Samuel A Neeve; Scott A Fisher; Jonathan Chee; Jason Waithman; Shao Kang Ma; Richard Lake; Anna K Nowak; Jenette Creaney; Matthew D Brown; Christobel Saunders; Bruce W S Robinson
Journal:  Cancer Immunol Immunother       Date:  2021-04-09       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.